Suppression of TNF receptor-1 signaling in an in vitro model of epileptic tolerance

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 3, Issue 2, 2011, Pages 120-132

  Thompson, Simon J ^a   Ashley, Michelle D ^a   Stöhr, Sabine ^a   Schindler, Clara ^a   Li, Minghua ^a   McCarthy Culpepper, Kristin A ^a   Pearson, Andrea N ^a,c   Xiong, Zhi Gang ^a,c   Simon, Roger P ^a,c   Henshall, David C ^b   Meller, Robert ^a,c  

^a LEGACY RESEARCH   (United States)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death; Epileptic tolerance; Neuroprotection; PKF242 484; Preconditioning; Seizure; TACE; TNF

Indexed keywords

FAS ASSOCIATED DEATH DOMAIN PROTEIN; L 685 485; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PKF 242 484; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; ELECTROPHYSIOLOGY; ENZYME INDUCTION; ENZYME INHIBITION; EPILEPSY; EPILEPTIC STATE; EPILEPTIC TOLERANCE; FOCAL EPILEPSY; HIPPOCAMPUS; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 79960142330     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Meldrum BS. Implications for neuroprotective treatments. Prog Brain Res 2002; 135: 487-495.
2. Fujikawa DG. Prolonged seizures and cellular injury: understanding the connection. Epilepsy Behav 2005; 7 Suppl 3: S3-11.
3. Jimenez-Mateos EM and Henshall DC. Seizure preconditioning and epileptic tolerance: models and mechanisms. Int J Physiol Pathophysiol Pharmacol 2009; 1: 180-191.
4. Jimenez-Mateos EM, Hatazaki S, Johnson MB, Bellver-Estelles C, Mouri G, Bonner C, Prehn JH, Meller R, Simon RP and Henshall DC. Hippocampal transcriptome after status epilepticus in mice rendered seizure damage-tolerant by epileptic preconditioning features suppressed calcium and neuronal excitability pathways. Neurobiol Dis 2008; 32: 442-453.
5. Blondeau N, Widmann C, Lazdunski M and Heurteaux C. Activation of the nuclear factorkappaB is a key event in brain tolerance. J Neurosci 2001; 21: 4668-4677.
6. Engel T and Henshall DC. Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis? Int J Physiol Pathophysiol Pharmacol 2009; 1: 97-115.
7. Vezzani A, French J, Bartfai T and Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7: 31-40.
8. Wajant H, Pfizenmaier K and Scheurich P. Tumor necrosis factor signaling. Cell DeathDiffer 2003; 10: 45-65.
9. McCoy MK and Tansey MG. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation 2008; 5: 45.
10. Clark IA, Alleva LM and Vissel B. The roles of TNF in brain dysfunction and disease. Pharmacol Ther 2010; 128: 519-548.
11. Stellwagen D. The contribution of TNFalpha to synaptic plasticity and nervous system function. Adv Exp Med Biol 2011; 691: 541-557.
12. Chen G and Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002; 296: 1634-1635.
13. Cheng B, Christakos S and Mattson MP. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994; 12: 139-153.
14. Liu ZG, Hsu H, Goeddel DV and Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996; 87: 565-576.
15. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW and Mattson MP. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996; 2: 788-794.
16. Gary DS, Bruce-Keller AJ, Kindy MS and Mattson MP. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J Cereb Blood Flow Metab 1998; 18: 1283-1287.
17. Hsu H, Xiong J and Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81: 495-504.
18. Westwick JK, Weitzel C, Minden A, Karin M and Brenner DA. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J Biol Chem 1994; 269: 26396-26401.
19. Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C and Levrero M. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997; 275: 200-203.
20. Varfolomeev EE and Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell 2004; 116: 491-497.
21. Wilson NS, Dixit V and Ashkenazi A. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 2009; 10: 348-355.
22. Balosso S, Ravizza T, Perego C, Peschon J, Campbell IL, De Simoni MG and Vezzani A. Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. Ann Neurol 2005; 57: 804-812.
23. Stellwagen D and Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006; 440: 1054-1059.
24. Balosso S, Ravizza T, Pierucci M, Calcagno E, Invernizzi R, Di Giovanni G, Esposito E and Vezzani A. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience 2009; 161: 293-300.
25. Shen HM and Pervaiz S. TNF receptor superfamily-induced cell death: redox-dependent execution. Faseb J 2006; 20: 1589-1598.
26. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275: 90-94.
27. Wang L, Du F and Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 2008; 133: 693-703.
28. Micheau O and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190.
29. Schutze S, Machleidt T, Adam D, Schwandner R, Wiegmann K, Kruse ML, Heinrich M, Wickel M and Kronke M. Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J Biol Chem 1999; 274: 10203-10212.
30. Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held-Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, Mentlein R, Kabelitz D and Schutze S. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 2004; 21: 415-428.
31. Henshall DC, Araki T, Schindler CK, Shinoda S, Lan JQ and Simon RP. Expression of deathassociated protein kinase and recruitment to the tumor necrosis factor signaling pathway following brief seizures. J Neurochem 2003; 86: 1260-1270.
32. Shinoda S, Skradski SL, Araki T, Schindler CK, Meller R, Lan JQ, Taki W, Simon RP and Henshall DC. Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci 2003; 17: 2065-2076.
33. Henshall DC, Bonislawski DP, Skradski SL, Lan JQ, Meller R and Simon RP. Cleavage of Bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures. Neurobiol Dis 2001; 8: 568-580.
34. Meller R, Clayton C, Torrey DJ, Schindler CK, Lan JQ, Cameron JA, Chu XP, Xiong ZG, Simon RP and Henshall DC. Activation of the caspase8 pathway mediates seizure-induced cell death in cultured hippocampal neurons. Epilepsy Res 2006; 70: 3-14.
35. Li T, Lu C, Xia Z, Xiao B and Luo Y. Inhibition of caspase-8 attenuates neuronal death induced by limbic seizures in a cytochrome cdependent and Smac/DIABLO-independent way. Brain Res 2006; 1098: 204-211.
36. Yamamoto A, Schindler CK, Murphy BM, Bellver-Estelles C, So NK, Taki W, Meller R, Simon RP and Henshall DC. Evidence of tumor necrosis factor receptor 1 signaling in human temporal lobe epilepsy. Exp Neurol 2006; 202: 410-420.
37. Araki T, Simon RP, Taki W, Lan JQ and Henshall DC. Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse. J Neurosci Res 2002; 69: 614-621.
38. Shinoda S, Araki T, Lan JQ, Schindler CK, Simon RP, Taki W and Henshall DC. Development of a model of seizure-induced hippocampal injury with features of programmed cell death in the BALB/c mouse. J Neurosci Res 2004; 76: 121-128.
39. Furshpan EJ. A cell-culture approach to the study of seizure activity. Q J Exp Physiol 1989; 74: 975-985.
40. Furshpan EJ and Potter DD. Seizure-like activity and cellular damage in rat hippocampal neurons in cell culture. Neuron 1989; 3: 199-207.
41. Xiong Z, Lu W and MacDonald JF. Extracellular calcium sensed by a novel cation channel in hippocampal neurons. Proc Natl Acad Sci U S A 1997; 94: 7012-7017.
42. Meller R, Schindler CK, Chu XP, Xiong ZG, Cameron JA, Simon RP and Henshall DC. Seizure-like activity leads to the release of BAD from 14-3-3 protein and cell death in hippocampal neurons in vitro. Cell Death Differ 2003; 10: 539-547.
43. Meller R, Minami M, Cameron JA, Impey S, Chen D, Lan JQ, Henshall DC and Simon RP. CREB-mediated Bcl-2 protein expression after ischemic preconditioning. J Cereb Blood Flow Metab 2005; 25: 234-246.
44. Hatazaki S, Bellver-Estelles C, Jimenez-Mateos EM, Meller R, Bonner C, Murphy N, Matsushima S, Taki W, Prehn JH, Simon RP and Henshall DC. Microarray profile of seizure damage-refractory hippocampal CA3 in a mouse model of epileptic preconditioning. Neuroscience 2007; 150: 467-477.
45. Vezzani A, Balosso S and Ravizza T. The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 2008; 22: 797-803.
46. de Bock F, Dornand J and Rondouin G. Release of TNF alpha in the rat hippocampus following epileptic seizures and excitotoxic neuronal damage. Neuroreport 1996; 7: 1125-1129.
47. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S and Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000; 12: 2623-2633.
48. Lee RH, Mills EA, Schwartz N, Bell MR, Deeg KE, Ruthazer ES, Marsh-Armstrong N and Aizenman CD. Neurodevelopmental effects of chronic exposure to elevated levels of proinflammatory cytokines in a developing visual system. Neural Dev 2010; 5: 2.
49. Engel T, Murphy BM, Hatazaki S, Jimenez-Mateos EM, Concannon CG, Woods I, Prehn JH and Henshall DC. Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma. FASEB J 2010; 24: 853-861.
50. Murphy BM, Engel T, Paucard A, Hatazaki S, Mouri G, Tanaka K, Tuffy LP, Jimenez-Mateos EM, Woods I, Dunleavy M, Bonner HP, Meller R, Simon RP, Strasser A, Prehn JH and Henshall DC. Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus. Cell Death Differ 2010; 17: 459-468.
51. Engel T, Caballero-Caballero A, Schindler CK, Plesnila N, Strasser A, Prehn JH and Henshall DC. BH3-only protein Bid is dispensable for seizure-induced neuronal death and the associated nuclear accumulation of apoptosisinducing factor. J Neurochem 2010; 115: 92-101.
52. Janser P, Neumann U, Miltz W, Feifel R and Buhl T. A cassette-dosing approach for improvement of oral bioavailability of dual TACE/ MMP inhibitors. Bioorg Med Chem Lett 2006; 16: 2632-2636.
53. Souza DG, Ferreira FL, Fagundes CT, Amaral FA, Vieira AT, Lisboa RA, Andrade MV, Trifilieff A and Teixeira MM. Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNFalpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice. Eur J Pharmacol 2007; 571: 72-80.
54. Trifilieff A, Walker C, Keller T, Kottirsch G and Neumann U. Pharmacological profile of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in models of airway inflammation. Br J Pharmacol 2002; 135: 1655-1664.
55. Cotman CW, Banker G, Zornetzer SF and McGaugh JL. Electroshock effects on brain protein synthesis: relation to brain seizures and retrograde amnesia. Science 1971; 173: 454-456.
56. Wasterlain CG. Inhibition of cerebral protein synthesis by epileptic seizures without motormanifestations. Neurology 1974; 24: 175-180.
57. Dwyer BE and Wasterlain CG. Selective focal inhibition of brain protein synthesis during generalized bicuculline seizures in newborn marmoset monkeys. Brain Res 1984; 308: 109-121.
58. Cheung MK. The specificity of glutamate inhibition of protein synthesis in synaptosomal fractions from rat cerebral cortex. Neurochem Int 1989; 15: 293-300.
59. Simon R, Henshall D, Stoehr S and Meller R. Endogenous mechanisms of neuroprotection. Epilepsia 2007; 48 Suppl 8: 72-73.